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Abstract 
Ethnopharmacological relevance:  
What are the minimum methodological and conceptual requirements for an 
ethnopharmacological field study? How can the results of 
ethnopharmacological field studies be reported so that researchers with 
different backgrounds can draw on the results and develop new research 
questions and projects? And how should these field data be presented to get 
accepted in a scientific journal such as the Journal of Ethnopharmacology? 
The objective of this commentary is to create a reference that covers the 
basic standards necessary during planning, conducting and reporting of field 
research. 
Materials and methods: We focus on conducting and reporting 
ethnopharmacological field studies on medicinal plants or materia medica and 
associated knowledge of a specific people or region. 
The article highlights the most frequent problems and pitfalls, and draws on 
published literature, fieldwork experience, and extensive insights from peer-
review of field studies.  
Results: Research needs to be ethical and legal, and follow local and national 
regulations. Primary ethnopharmacological field data need to be collected and 
presented in a transparent and comprehensible way. In short this includes: 1) 
Relevant and concise research questions, 2) Thorough literature study 
encompassing all available information on the study site from different 
disciplines, 3) Appropriate methods to answer the research questions, 4) 
Proper plant use documentation, unambiguously linked to voucher 
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specimens, and 5) Qualitative and quantitative analyses of the collected data, 
the latter relying on use-reports as basic units. 
Conclusion: Although not exhaustive, we provide an overview of the 
necessary main issues to consider for field research and data reporting 
including a list of minimal standards and recommendations for best practices. 
For methodological details and how to correctly apply specific methods, we 
refer to further reading of suggested textbooks and methods manuals.  
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1. Introduction 
In spite of the Journal of Ethnopharmacology (JEP) having established the 
“Rules of 5”: https://www.elsevier.com/__data/promis_misc/jeprulesof5.pdf) as 
well as a journal checklist to be completed upon submission 
(https://www.elsevier.com/__data/promis_misc/JEP_AuthorChecklist.pdf), 
which should help to guarantee a minimum standard of the submitted studies, 
from a reviewers’ perspective, too many manuscripts are rejected because 
they lack minimal standards of field research and data presentation. This is a 
regrettable situation considering the time spent by researchers and the 
potentially valuable data being lost.  
With respect to field studies, the Rules of 5 state that “ethnopharmacological 
and ethnobotanical surveys normally need to report primary (absolute) data 
reporting how many times a (botanical) drug has been cited for a certain use 
and application”. The journal checklist additionally asks: “Have you provided 
absolute/primary data on the frequency of plant use as mentioned in the 
interviews? And is there a critical assessment of the traditional uses 
considering regional and global uses and known scientific information on the 
chemistry and biological effects?” and “Have you provided full botanical plant 
names, including authorities of all plants?”. 
The objective of this commentary is to create a reference explaining the rules 
of 5 in more detail concluding with bullet points in the form of “minimal 
standards” and “recommendations” addressing some of the more frequent 
issues encountered in submitted manuscripts. It is not intended as a methods 
manual, but rather to communicate lessons learned by a group of researchers 
and insights obtained by acting as referees to pinpoint potential pitfalls during 
planning, conducting and analysing field research. While complementary to 
the consensus statement on ethnopharmacological field studies (ConSEFS) 
(see Heinrich et al., 2017) this article is more specific to the requirements of 
the Journal of Ethnopharmacology and goes more into details.  
In addition to key texts in research methods (e.g., Bernard 2011; Newing 
2011) various ethnobotany methods manuals are available that can be 
consulted (e.g., Martin, 1995; Alexiades, 1996; Cotton, 1996; Cunningham, 
2001). Also several influential papers have been published on standards in 
the field of ethnopharmacology (Berlin and Berlin, 2005; McClatchey, 2006; 
Gertsch. 2009; Heinrich et al., 2009) and many good examples of published 
field research exist. 
 
 
2. Why do research? 
Often, the expressed rationale for ethnopharmacological studies is that no 
previous research has been conducted in a specific location or among those 
specific people. This is a valid argument that satisfies a curiosity-driven need 
to document traditional knowledge. However, such a rationale should at least 
specify why this area or those people are of interest and relevant for the 
specific research question. Studies should not only be descriptive, but rather 
address specific research questions and testable hypotheses, and contribute 
to disciplinary debates and conceptual frameworks that can advance the field 
and relate to contemporary issues in both scientific and public spheres (see 
also Heinrich et al., 2009).  
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Similar critiques can be raised of another common rationale for 
ethnopharmacological research, given in both rejected and accepted papers, 
that “80% of the people in developing countries use traditional medicine as 
their primary source of healthcare”. Apart from the fact that this statement is 
unsubstantiated1, such a general proposition can only justify research to test 
its claim, or perhaps underpin a generic disciplinary aim of studies of 
traditional medicine, but otherwise offers no theoretical motivation for any 
particular ethnopharmacological study.  
Frequently, studies refer to the need to document traditional herbal knowledge 
to foster local health care, save it for future generations, as well as for 
potential drug discovery. However, the paradigm that ethnopharmacological 
research is still of significant relevance to conventional drug discovery has 
been challenged (Gertsch, 2009). Several studies have pointed out the 
dynamic character of traditional medical knowledge, and argued that 
acculturation and globalization is not a priori detrimental but rather that 
amalgamation of traditional with new knowledge systems can help people to 
adapt to new realities. Ethnopharmacology should clearly address its 
significance for those outside the academic community and research should 
be based on a partnership with local participants. It is meaningful to consider 
together with the participants how ethnopharmacological studies can 
contribute to for example livelihood improvement and how useful information 
can be exchanged (e.g., Jäger, 2005). Indeed, with the recent development of 
institutional codes of ethics, especially with regard to Free Prior Informed 
Consent (FPIC; e.g., ISE 2006), and the requirements of both national 
research regulatory agencies and international agreements (e.g., Convention 
on Biological Diversity, 1992; CBD Nagoya Protocol on Access and Benefit 
Sharing, 2014), almost all field research in ethnopharmacology and 
ethnobotany must be supported by research agreements that specify means 
for dissemination of research results, outreach to participants, and even 
potential benefit sharing arrangements (e.g. Gamborg et al., 2012).  
Based on the above, scholars in ethnopharmacology need to critically 
consider the importance of their research: Given the global base of conducted 
ethnopharmacological field studies, what kind of new information do we hope 
to retrieve? In which way are these studies going to contribute to the scientific 
understanding of traditional medicine and herbal drugs? How does our 
research contribute to cultural documentation and improve the livelihoods of 
local participants? 
 
 
3. Research Questions  
All effective and significant research is guided by research questions that 
potentially provide answers that close gaps in knowledge. However, 
meaningful research questions and relevant ethnomedical information or 
quantitative analyses leading to the interpretation of the traditional health care 
                                                 
1
 Attributed to the World Health Organization (WHO Fact Sheet 134 of 2003) but currently not 
being promoted in the latest Traditional Medicine Strategy of the WHO (WHO, 2013). 
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situation are often lacking in the manuscripts submitted to JEP. On the other 
hand, the general push of journals for quantitative studies often results in the 
uncritical use of all kinds of indices. 
While the guiding and inherent question of most ethnopharmacological field 
studies is “What plants do people use as medicine?” it would be important that 
contemporary research goes beyond this fundamental knowledge and 
develops additional questions or tests derived hypotheses. For instance, “Why 
is plant species X used for so many diseases? Why are so many plant 
species used for one particular disease?” In Sub-Sahara Africa, for example, 
one of the major use categories in the trade in herbal medicine (in both 
number of species and volumes sold) is female reproductive health (Van 
Andel et al., 2012; Towns et al., 2014). This observed phenomenon almost 
automatically leads to several hypotheses:  
 
1) Women probably have limited access to modern medicine 
2) Women prefer plants to treat reproductive ailments  
3) Women need plants for certain aspects of reproductive health that modern 
medicine cannot offer them (e.g., abortifacients). 
  
Such hypotheses can be tested by including questions about these subjects in 
interviews (for example, asking female customers for their motivation to use 
herbs) and by collecting data on national reproductive health statistics. In 
anthropological papers, one can retrieve information on the local aetiology of 
illnesses that are often treated with traditional medicine. In this way the data 
from ethnopharmacological surveys can be contextualized, which makes the 
research much more interesting to public health authorities and medical 
anthropologists than just a list of plants and their uses. 
Research questions should be clearly and concisely written, focused on 
descriptive as well as explanatory objectives (e.g., When do residents avoid 
government health clinics?) that illuminate the relationships between concepts 
or categories associated with the topic of interest. Research questions are 
ultimately non-trivial if they lead to answers that contribute to knowledge 
production, advancement of the discipline, and/or solve problems, as 
discussed above. It is helpful to develop site selection criteria that set out the 
optimal characteristics desired for a particular location to pursue the research 
questions. This is especially important when planning comparative studies 
where it is necessary to control for variation in a limited number of variables 
among sites in order to test hypotheses. 
It is expected that research proposals or manuscripts clearly state their 
research questions and how these were derived in an introduction. The rest of 
the manuscript will follow from these questions. Submitted manuscripts are 
often too long because the authors do not keep themselves to specific 
questions and hypotheses. Posing research questions and hypotheses helps 
to maintain order in the manuscript, and identify those issues and data that 
are relevant. 
 
4. Methods 
In this section, we analyse some of the main problems in using and reporting 
research methods in ethnopharmacological research.  
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4.1. Selection and description of study site and participants 
A description of the available local health care providers contextualizes the 
use of traditional medicine. Along with the overall health care options, the 
epidemiologic and ethnographic background and the rationale of people’s 
health seeking behaviour can be put into perspective, and accommodate the 
research questions. 
Ethnographic details of the study’s local participants complement the scientific 
rationale, which lead to the selection of the study site. Historical, economic, 
political, social and cultural characteristics may be key variables, and details 
of these aspects should be included for the investigative framework. 
Additionally information including references providing further detail to the 
biome, the climatic conditions and the geography can help to contextualize 
the study, and these should be provided. Here it is important to avoid referring 
to compilation websites, but cite specific objective sources for all information. 
In cases where respondents do not want their location to be published, or 
researchers fear potential harm to their respondents for participating in the 
research, pseudonyms can be used and any maps need to be of sufficiently 
large scale to prevent identification of study sites. Non-disclosure of such 
information must be well motivated in the manuscript.  
 
4.2. Selection and description of respondents 
Depending on if the study focuses on the general knowledge of a population 
or on specialists’ knowledge the sampling strategies and the number of 
included participants differ (Bernard 2011; Newing, 2011). Of particular 
relevance here are several social characteristics of ethnomedical systems that 
have a bearing on sampling (see Zent and Maffi, 2008). It is already known 
that knowledge and use of medicinal plants, for instance, is gendered 
(Howard, 2003; Pfeiffer and Butz, 2005), and that knowledge is differentiated 
by age, with younger people generally knowing less than elders. This can be 
even more pronounced when levels of education are factored in, whereby 
formal schooling, even close to home, may influence a child’s acquisition of 
traditional knowledge (Reyes-Garcia, 2013). Typically, there is also a 
distinction between generalist and specialist knowledge, whereby the general 
populace normally has a lower level of knowledge, while specialist healers, 
herbalists, doctors or shamans hold the bulk of medicinal plant knowledge as 
well as comprehension of the ethnomedical system. Where plant collecting is 
a distinct occupation or a specified social role, we can expect plant collectors, 
or traders, to have different knowledge compared to those specialists that 
make, sell (pharmacists, market vendors) and administer medicines (healers, 
doctors). Similarly social class, caste and religion may also create variation. 
Social segmentation means that knowledge and use of medicinal plants 
varies across all study populations, and in fact, the relationship between 
knowledge and practice may also vary, whereby younger people may know of 
plants and their uses, but be less skilled in identifying drugs or compound 
medicines. This shift from substantive to more theoretical knowledge of 
traditional medical systems is an important subject for contemporary research 
(Zent and Maffi, 2008; Reyes Garcia et al., 2009; Puri, 2013). Therefore, 
selecting participants for research should consider this complex variation and 
explain why certain groups of the population were included and others not.  
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Another sampling choice is the unit of analysis, and individuals, households, 
communities or language groups may be sampled. Common errors in analysis 
are overgeneralizations of results to a much larger population than sampled. 
Likewise one cannot speak of individual variation when data was collected in 
focus groups or community meetings. However, if you wish to use quantitative 
analyses, make sure you have a sample that is sufficiently representative to 
test your hypotheses. The best way to achieve this is to consult specific 
literature (e.g. Kadam and Bhalerao, 2010; Bernard, 2011) or a statistician 
before you start sampling.  
To analyse collected data from respondents, and to write a proper methods 
section in a research paper, information about the interviewed people needs 
to be recorded. This can be presented in a summary table or an appendix, 
and includes as a minimum, and in an anonymised form, sex and age of the 
respondents. Usually, information about ethnicity, religion, primary and 
interview language, literacy and schooling, and occupation of respondents is 
collected too, and, if appropriate, marital status and family size depending on 
the necessities of the specific project. 
 
4.3. Duration of thorough field research 
The ideal field study would last more than a year, to capture the full floral, 
agricultural and cultural cycle. There may be seasonal differences in both 
illnesses and the availability of plant remedies and this may affect the way 
respondents discuss these topics. Markets also vary by season, so 
inventories and interviews with both sellers and consumers should be 
repeated to capture this variation. Given the interdisciplinary nature of 
research, bringing in specialist experts, botanist or medical doctors for 
instance, might help to enrich or facilitate data gathering. Botanists may be 
able to identify sterile specimens in the field, doctors may help understand 
local medical systems and veterinarians may help understand local animal 
illnesses. Another solution, in certain circumstances, may be to train local 
participants as interviewers or plant collectors to increase the sample set in 
the given time period. Key here is to realize the limitations of a study covering 
less than a full year, and to discuss them in the manuscript. 
Similarly, if the research project and the local situation allows, it might be 
good practice to document the whole materia medica or medicinal flora of a 
community or a population, not just parts thereof. This also includes 
contextual aspects such as the relationship between people and the medicinal 
plants. While scientists tend to see plants as “natural resources”, for local 
participants they may be living organisms, which are part of an intricate 
kinship network.  
The overall profile of a plant’s use(s) gives important information (including 
local respondents’ rationales) for further (ethnopharmacological) research, 
while focusing on specific diseases and ailments bears the risk of 
decontextualizing plant use and ethnopharmacology in general. Exceptions 
are treatment outcome studies, which need to focus on a specific health 
condition or disease (e.g., Willcox et al., 2011). If a field study does focus on 
specific therapeutic uses, a sound scientific motivation or a reason related to 
pressing health issues should be evidenced, while the reported data is 
expected to be comprehensive. Most manuscripts submitted to JEP focusing 
on a specific ailment or disease group do so without any particular scientific 
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motivation. Publishing subsets of field data causes unnecessary 
fragmentation and risks distorting research results, while more comprehensive 
papers are often more valuable for future research.  
 
 
4.4. Collecting Plants 
The challenge during ethnopharmacological field research is to link collected 
local plant names with plant samples (Rivera et al. 2014; Bennett and Balick, 
2014). Ideally, one should collect voucher specimens with each respondent 
for all plants mentioned during interviews. Studies need to report the means 
and sources of plant identification, the institutions holding the voucher 
specimens, and the experts that have helped to identify these samples. Some 
challenges in terms of scientific rigor that scholars in ethnopharmacology face 
are: 1) Collection of complete specimens for herbarium vouchers; 2) Linking 
names mentioned during interviews to plants collected during subsequent 
voucher collecting; 3) Exhaustive collection of vouchers for ethnotaxa; 4) Use 
of visual aids for identification; 5) Depositing ethnobotanical voucher 
specimens as herbarium vouchers and their retrieval; and 6) Identifying and 
applying accepted scientific names. 
For some regions field guides for sterile plant material exist (e.g., Gentry 
1993). Otherwise, one may try to augment sterile material, for example, with 
old fruits lying on the floor below the plant collected or germinated seedlings 
with seeds attached. They can be dried and included, but labels must specify 
this, e.g., "old fruits collected from forest floor”. Also, local guides can be 
asked to describe the flowers and fruits of the collected plant. Again, voucher 
labels should record this as, for instance, "fruits are said to be flat and as big 
as a machete". These clues can aid identification later on, even though the 
collector has not observed them. For details on how to collect herbarium 
specimens we refer to the Herbarium Handbook (Bridson and Forman, 2013). 
Linking local plant names to taxonomically accurate botanical taxa is essential 
to ethnopharmacological research. A key issue in this regard is the under- or 
over differentiation of ethnotaxa in comparison to Linnaean binomial 
nomenclature, such as species referring to several ethnotaxa and vice versa. 
It is therefore important to collect voucher specimens on site with all interview 
partners and ask about possible ethnobotanical ambiguities (Berlin, 1973). In 
addition it is important to use currently accepted names and author 
abbreviations when referring to scientific taxa. Cross-referencing names found 
in local floras with more versatile online databases, such as the Medicinal 
Plant Names Services Portal (http://mpns.kew.org/mpns-portal) or The Plant 
List (http://www.theplantlist.org/), is necessary to avoid using older synonyms. 
The use of pictures should always be avoided to elicit initial responses, and 
visual aids in general should only be used to disambiguate. Authors are, 
however, encouraged to provide links to high resolution scans of the 
herbarium vouchers in either the main manuscript or as supplementary data. 
These should be fully curated specimens with databased voucher information. 
These scans should be stored in permanent digital resources independent of 
the journal. This enables identification of the vouchers by other people than 
the authors or specialists working in that herbarium. In addition, digital 
photographs taken of living material in the field can be included to strengthen 
the botanical value of the paper. In this case, these should be deposited in 
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independent digital data repositories that provide digital object identifiers 
(DOI), such as DRYAD (https://datadryad.org/).  
 
 
5. Data handling, systematization and presentation  
All research articles should describe their methods used to allow others to 
replicate the study as far as possible. This applies to the gathering of the 
original primary data collected for answering specific research questions, as 
well as to the data analysis tools (e.g. Verpoorte, 2012; Baker, 2016).  
The cultural context of plant use can generally be well addressed with 
qualitative data while the frequency of specific actions can be measured with 
quantitative data (Bernard, 2011). Therefore, they complement each other 
and may result in a presentation of ethnopharmacological field data (mostly 
quantitative) in its sociocultural context (mostly qualitative) highlighting the 
role of ethnomedicine among local health care options. 
 
 
5.1. Qualitative data 
Qualitative data can be obtained through direct observations (so-called 
participant observation; for details and challenges see Bernard (2011) and 
Newing (2011)) as well as interviews, and is descriptive. The description of an 
ethnomedical or local medical system with its different types of healers, health 
care facilities, emic/local disease aetiologies and categories is usually 
presented qualitatively. The explanations given by the healers regarding the 
healing properties of the applied remedies is the kind of information that helps 
the researcher to understand emic healing concepts. Also reporting names of 
medicinal plants, descriptions of processes such as the precise preparation of 
medicines (recipes) and the prearrangement for a ceremony calls for a 
qualitative approach. 
During data analysis qualitative data are often organized, e.g., through 
categorizing descriptions of sickness, into emic or biomedical categories of 
use for the assignment of use reports (quantitative data). The methods 
section of any paper should explain how the collected data is being quantified 
and which criteria were used to categorize emic descriptions of sickness (e.g., 
Berlin and Berlin, 1996; Staub et al., 2015). As already mentioned above, 
categories of use are important for descriptive statistics, for quantitative 
analysis and cross-cultural comparisons (Leonti and Weckerle, 2015). They 
arrange specific health conditions and symptoms into more or less well 
defined groups of therapeutic domains (e.g., skin, digestive, neurological, 
psychological).  
What becomes apparent when reviewing or reading ethnopharmacological 
studies is that researchers often report their own interpretation of ailments 
reported by healers and, additionally, categorise them according to etic 
criteria. For instance, vague terms such as “bellyache” are translated as 
"gastro-intestinal disorders", "colics" or "appendicitis", or even more specific 
medical terms such as gastrointestinal inflammation. Emic categories can be 
investigated by using a combination of freelisting and pile sorting (Bernard, 
2011; Puri, 2011). Most traditional healers do not have the necessary 
background to diagnose all ailments properly, and may not use biomedical 
terms at all. As long as not medically trained personnel diagnose patients in 
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the field, the International Classification of Diseases (ICD) by the WHO or the 
‘Economic Botany Data Collection Standard’ by Cook (1995) cannot be 
meaningfully applied for the classification of remedies, ailments and diseases 
reported by local participants. An alternative classification system accepted by 
the WHO is the ICPC (International Classification of Primary Care). This 
system is used in general family practice and primary care allowing 
“classification of the patient’s reason for encounter” 
(http://www.who.int/classifications/icd/adaptations/icpc2/en/) and can 
therefore reasonably be applied to collected ethnomedical data for 
comparative purposes (Staub et al., 2015). 
One needs, however, to consider that patients can get their diagnosis from 
trained physicians and/or outpost clinics and subsequently ask for a remedy 
from a local healer or herbalist. Also therefore, background information about 
the local health care facilities (biomedical and alternative medicine) and 
peoples’ attitudes towards choosing their medicine should be provided in a 
manuscript. Other qualitative data important for contextualizing quantitative 
field-data is information about the origin of medical knowledge and knowledge 
transmission in general. While not all researchers will be interested in the 
history or the transmission of ethnomedical knowledge, asking respondents 
from where or whom they acquired their knowledge is increasingly seen as 
important given the increased access people have to media and other 
information technology, as well as the long histories of contact and exchange 
(pre-colonial and colonial) in most parts of the world.  
For the different types of qualitative and quantitative analysis we refer to 
Bernard (2011).  
 
 
5.2. Quantitative data 
Quantitative data are amenable to statistical manipulation and analysis. 
Identifying drugs or remedies that are most heavily relied upon (most 
frequently mentioned is then often used as a proxy) for a certain ailment or 
disease category are among the most common research goals of 
ethnopharmacological field studies. Important key data are the number of 
local participants that were interviewed during a survey. The frequency of 
citation of a specific remedy, that is, the number of individual use-reports (nur) 
for a type of drug and its therapeutic application, serves to establish the 
consensus across the respondents. The cultural consensus on healing 
properties of remedies and drugs can help to inform subsequent laboratory 
studies that aim at evaluating their efficacy and toxicology (Trotter and Logan, 
1986; Berlin and Berlin, 2005; Heinrich et al., 2009). 
Primary data is usually presented in the form of use-reports. A use-report can 
be defined as an individual report of a specific taxon/drug for a certain 
category of use, a specific ailment, disease or symptom. However, use-
reports can be defined differently and therefore it is important to give a 
working definition.  
Differentiating use-reports by the level of specific diseases, ailments or 
symptoms, and considering the kind of drug used (e.g., root, seeds, herb, 
bark), will result in more detailed use-reports with lower frequencies and 
render downstream analysis more complex. Additionally, other variables 
contained in a recipe can be considered in the definition of a use-report, 
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including different modes of preparation (e.g., infusion, cataplasm, bath) and 
application (internal, external, fumigation, enema). However, since plant-
based remedies are often used for many specific conditions within the same 
category of use, and since different parts of the same taxon can often be 
applied interchangeably, it normally makes sense to define a use-report 
through the local participant, the category of use and the taxon. 
The first step of data analysis usually consists in the quantitative evaluation of 
use-reports assigned to emic categories of use. For plant species that are 
common in mixtures, more use-reports are usually collected, and this may 
result in over-emphasizing of those categories of use containing many 
components of drug mixtures. Also, if a drug’s uses are counted separately for 
every specific ailment (e.g., dermatologic problems: pimples, pustules, acne, 
shingles, wounds, eczema, etc.) the importance of use categories 
encompassing many distinguishable ailments will be further emphasized or 
inflated. Generally it is convenient to keep the definition as basic as possible 
but this depends on the specific research question. 
 
5.3. Presentation of data 
As an interdisciplinary field of research providing primary data and a scientific 
nexus with disparate research projects as well as scientists with different 
training backgrounds, it is important that ethnopharmacological field data is 
presented as intuitively and straightforward as possible. The collected primary 
data should be presented in a genuine and unaltered form, which allows the 
scientific community to use these raw data for different approaches and  
interpretations. Such ‘raw data’ presentation also facilitates reproducibility and 
guarantees transparency. For ethnopharmacological field studies this implies 
that the emic, or local description of a remedy’s use is reported and 
differentiated from the researcher’s (etic) interpretations presented in the 
discussion of the data (Headland, 1990; Leonti and Weckerle, 2015).  
Usually the quantitative primary data or raw data obtained through 
ethnopharmacological field studies is presented in table format embedded in 
the research article or made available in the appendix or as supplementary 
data. It is useful to follow a table structure where the rows are associated with 
either ethnotaxa or plant taxa and the columns with the specific associated 
information: 
 
1. Plant name: Scientific binomial name including abbreviated author name 
2. Plant family: Follows the most recent classification 
3. Vernacular name in the primary language (indicated) by the local 
participants 
4. Vernacular name in official language in region, country 
5. Herbarium voucher number (collector or code and collection number) 
6. Uses: Use-category (emic or etic) followed by (nur) and specific uses 
followed by (nur); other use-category (nur) [and continued in this vein] 
7. Drug: Plant parts used per use-category and specific uses with (nur) 
8. Preparation per use-category and specific uses with (nur) 
9. Mode of application per use-category and specific uses with (nur) 
10. Healing virtue: Emic rational (e.g. hot/cold, organoleptic property) 
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5.4. Quantification of use-reports and transformation of primary data 
If one writes that out of 100 local participants 50 report using the inflorescence 
of Chamomile (Matricaria chamomilla L.) in the form of an infusion to treat 
bellyache in general, 15 to treat flatulence, 10 to treat gastritis, 50 to treat 
nervousness, and another 30 to treat menstrual problems, whereas 25 use 
the essential oils to treat skin conditions such as eczema, then researchers 
from all backgrounds will get an idea about the pattern of variation regarding 
the medical use of this plant. Such a quantification of anecdotal reports about 
the use or effectiveness of remedies in relation to the absolute number of 
participants interviewed can guide the selection of plant compounds for 
experimental studies (Trotter and Logan, 1986).  
The results of ethnopharmacological field research are often quantified in the 
form of indices, e.g., cultural value, fidelity level, relative importance, use 
value, local participants agreement ratio or relative frequency of citation (see 
Dudney et al. (2015) for a comparative analysis of such indices). A key issue 
of such indices is that they are difficult to interpret and compare, especially 
when different uses, often also including non-medicinal uses, are subsumed 
within the same index, e.g. “the relative frequency of citation of Matricaria 
chamomilla is 0.85, the fidelity level is 80% and the use value 1.15”. 
It also seems that the most widely applied indices are not very specific, as the 
produced values seem to correlate across formulas, while the design of the 
study, especially the selection of the participants, can have a pronounced 
impact on the values (Dudney et al., 2015). In addition to the limited relevance 
of these indices for readers, their statistical value is questionable, as they do 
not consider variance of the data2.  
Moreover, the concepts of “importance” and “value” are context dependent 
and subjective, and render indices used to describe the significance of 
traditional drug use problematic.  They may also be misleading: An effective 
cure used for a rare and severe disease might get fewer citations by a local 
population than a remedy used for frequent ailments, but this does not 
automatically imply that the former has less value to these people. Since 
ethnobotanical indices are frequently presented instead of primary data, often 
without referring to specific therapeutic applications and moreover ignoring 
the uncertainty around sampled data, their application has resulted in many 
studies that are difficult to comprehend.  
                                                 
2 Common to all these indices is the lack of a measure for the probability distribution, 
e.g. the variance of the data, which also precludes these indices from being compared to 
other studies. In statistics, equal proportions, such as five out of ten (5/10) (e.g., five 
respondents out of ten mentioned the same use), twenty-five out of fifty (25/50) or fifty out of 
hundred (50/100), are not the same thing because of the different variance surrounding these 
data. Given a certain proportion p, its standard deviation is the square-root (SQRT) of (p(1-
p)/N), where N is the sample size used to calculate p and the denominator of the fraction. 
Using the central limit theorem the true proportion lies within p ± 1.96 × SQRT(p(1-p)/N) with 
a probability of 95%. In practice the difference between proportions can be claimed with a 
certain probability when their respective intervals do not overlap (e.g., Watt et al. 2007). 
The same is true for the Jaccard index (JI = (c/a+b+c) x 100), which derives from community 
ecology and is occasionally used for assessing the similarity of pharmacopoeias and medical 
floras. Imagine two datasets (medicinal flora or therapeutic uses) with sample a=100 and 
sample b=100 and an overlap of c=50. While the JI delivers a similarity index of 33.3%, the 
actual overlap is 50%. 
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In the form that ethnobotanical indices are currently applied they are not 
amenable to comparative ethnopharmacology, meta-analysis or hypothesis 
testing. The statistical power might rise if different formulas are adapted to 
include variance and when they refer to specific categories of use or 
applications2. However, when the primary data is presented in a transparent 
way anyone can theoretically use that data to calculate any indices he/she 
might wish to, and thus manuscripts should ensure accessibility to the primary 
data. 
 
 
6. Research permits and ethics  
Research permits and ethical issues are the two single most important 
aspects that can lead to the rejection of even scientifically brilliant papers. 
Until the last decade of the 20th century, ethnobiological research was little 
regulated on a global scale, and even the collection of biological materials 
was governed by few restrictions other than the Convention on International 
Trade in Endangered Species of Wild Flora and Fauna (CITES), and import 
regulations of many countries that required a Phytosanitary Certificate that 
would certify that biological material was not carrying any disease agents. 
This practice changed with the Convention on Biological Diversity (CBD) 
coming into effect in 1992, and, especially from the perspective of 
ethnobiological research, with the coming into effect of the Nagoya Protocol 
on Access to Genetic Resources and the Fair and Equitable Sharing of 
Benefits Arising from their Utilization (Nagoya Protocol) in 2014, although the 
USA for example has not ratified either treaty, and many countries have not 
yet ratified the Nagoya Protocol. 
The CBD for the first time assigned genetic resources as property to national 
states. Based on this guideline, all signatory countries (at present 196) were 
required to develop legislation to implement the CBD, including legislation on 
regulating collection and export of biological material. The provision declared 
in article 8(j) of the CBD had very little effect in practical research, because 
access to knowledge basically remained unregulated. This changed entirely 
with the Nagoya Protocol (now ratified by 76 countries).  
The Nagoya Protocol clearly assigns the property rights of traditional 
knowledge to the respective knowledge holders. The main objective of the 
protocol is "the fair and equitable sharing of benefits arising from the 
utilization of genetic resources...” including that "traditional knowledge 
associated with genetic resources held by indigenous and local communities 
is accessed with the prior and informed consent or approval and involvement 
of these indigenous and local communities and that mutually agreed terms 
have been established. Any community work is performed under the Nagoya 
Protocol on Access to Genetic Resources and Equitable distribution of 
benefits from their use, and that the right of use and ownership of any 
traditional knowledge of all informants remains with them, and that any use of 
the information except for scientific publication, requires the additional 
consent of the traditional owners, and consensus on access to benefits 
derived possibly later use.” (CBD, Nagoya Protocol 2014). These treaties 
have several implications for research ethics and permits. 
 
6.1. Ethics 
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Ethical research, in all cases, is research that does not negatively impacts 
participants of the research. Ethnopharmacological research often takes place 
among marginalized people, and working with them on an equal partnership 
basis and empowering them through collaboration and exchange is essential 
in participatory research. Researchers also need to be sensitive both during 
research and when presenting their data to not imply that local knowledge is 
somehow inferior to scientific knowledge. In many cases, authors of scientific 
papers regard local counterparts simply as “informants” or “study subjects”, 
whereas their contributions should be fully acknowledged through co-
authorship or duly acknowledged in the appropriate section of the paper. 
Similarly, local knowledge documented during research, as well as its further 
implications and use, are often regarded as the property of the researchers or 
scientific institutions involved, but this is an outdated view on research. 
Researchers should consider beyond the legally binding regulations for 
research permits what impact their research may have on local people’s 
rights, livelihoods and culture. For details on intellectual property rights issues 
we refer to the ‘World Intellectual Property Organization (WIPO) TK 
Documentation Toolkit’ (https://www.cbd.int/tk/wipo.shtml). 
Ethnopharmacological field research should always include clear 
arrangements with local counterparts and legal entities, even though official 
regulations might not exist. After implementation of the CBD, many research 
institutions around the globe set up “Internal Review Boards (IRB)” to screen 
research proposals involving human “subjects.” At the very least, any paper 
should include written evidence or a reference number of such ethical 
approvals, provided the institutions of the authors have such a board. 
However, based on the stipulations of the Nagoya Protocol, a simple “ethics 
approval” by a researcher’s IRB is not sufficient to allow publication. Many 
journals do, in fact, require additional written evidence that local law, as well 
as community regulations were followed. In the former case, a research 
permit number, or an indication which entity granted the permit to do 
research, should be provided. In case of the latter, an indication of how 
permits from local and indigenous communities or participants were obtained 
should be included.  
Normally, information on Free Prior Informed Consent (FPIC) is required for 
any publication. The concept of FPIC is, however, problematic for two 
reasons: On the one hand, many journals are not content with oral FPIC, as 
practiced, especially in ethnobiological studies. On the other hand, in many 
research settings, a request for written FPIC creates distrust among 
participants, because signing papers is simply not common, and the content 
of a FPIC disclosure might be hard to understand. Under such circumstances, 
the best choice for researchers is to provide a statement on what kind of FPIC 
they obtained, and to state if they followed a specific code of ethics. For 
ethnobiological research, the current standard is the International Society of 
Ethnobiology (ISE) Code of Ethics (ISE 2006). 
It should be noted that under the Nagoya Protocol, FPIC does not only refer to 
consent from community leaders, but from each individual participant in the 
research. In addition, it has to include arrangements about benefit-sharing, as 
well as recognition of the intellectual property rights of the respective 
participants and their communities. While not all countries have ratified the 
Nagoya Protocol, most, especially Western, researchers are bound by it. 
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Researchers working in the European Union for example are legally required 
to comply with the Nagoya Protocol, because the EU has ratified it. While the 
USA has not ratified the Nagoya Protocol, US researchers are still required to 
comply with it when it comes to the import of biological material and 
associated knowledge.  
 
6.2. Research permits  
The lack of appropriate research permits might provide a similar reason to 
reject a paper. Based on the CBD, most countries require researchers to 
obtain clear permits for the collection of biological specimens. Such permits 
normally state explicitly where collections can be done, what can be collected, 
and how many samples (or duplicates) are permitted. In most cases a 
research permit will also stipulate where the collection has to be deposited 
(generally half of all individual specimens, as well as unicates and types are to 
be deposited in the host country). Export of specimens normally requires that 
researchers prove that the required material has been deposited at a national 
institution in the host country. Both research and export permits are, in most 
cases, required to legally import material into any country a researcher might 
reside in. After the ratification of the Nagoya Protocol, most host countries 
require additional permits for studies involving traditional knowledge. 
Generally, a written permit from local or community councils or similar entities 
is required, before a research permit will be issued by the respective National 
Focal Point. It is important to note that the community permit does also need 
to be based on FPIC, and does have to include any stipulation on benefit-
sharing, intellectual property rights (for example stipulation on whether or not 
participants will be named as authors), and any wording related to possible 
future use of such knowledge. 
 
7. Conclusions 
We conclude this commentary with a bullet list of minimal standards and 
recommended practices, which we condense from the above explanations 
and discussion. 
 
 
7.1 Minimal standards 
 
-Methods used should be described in a way so that others can replicate the 
study as far as possible. 
 
-Explain why the research area and local participants are of interest and 
relevant for the specific research question. 
 
-Description of study site and local participants: Along with the overall health 
care options, the epidemiologic and ethnographic background, the rationale of 
people’s health seeking behaviour can be put in perspective and 
accommodates the research questions. 
 
-Describe the selection of respondents, and provide basic information about 
age and gender. 
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-Method of information collection, e.g., informal, unstructured, semi-structured 
interviews, focus groups, freelist questions, questionnaires, participant 
observation should be specified. In addition who conducted the interview and 
which language was used during the conversation? What kinds of questions 
were asked?. 
 
-Explain criteria and methods used for establishing therapeutic use-
categories.  
 
-Document the legal right to collect and transport plants or voucher 
specimens. For studies involving traditional knowledge a written permit from 
local or community councils or similar entities is also required. 
 
-Specify source of accepted species and family names through nomenclature 
standards (e.g., http://mpns.kew.org/mpns-portal or 
http://www.theplantlist.org/).  
 
-Voucher specimens should whenever possible be deposited in an officially 
recognized herbarium that is located at a recognized institution and committed 
to the long-term maintenance of its collection.  
 
-For reporting primary data and in order to use field-data as a guide for 
laboratory studies it would be important to know how many local participants 
mentioned/cited each of these specific uses. This means you should report 
the frequency of citation (or use-reports) per species, drug, application and 
use (and not number of citations per plant taxon or relative data). 
 
(See also rules of 5 and journal checklist) 
 
 
7.2 Recommendations for best practice 
 
-Address specific research questions and contribute to disciplinary debates, 
and conceptual frameworks that can advance the field and relate to 
contemporary issues in both scientific and public spheres.  
 
-Working with local people on an equal partnership basis including 
collaboration and knowledge transfer. 
 
-Participant observation is used to collect contextual information and for 
verification of interview results.  
 
-The ideal field study covers a full floral, agricultural and cultural cycle and 
therefore would last at least a year. 
 
-It’s a good practice to interview participants more than once at different 
periods of the year to capture seasonal differences in illnesses, availability of 
plant remedies and market inventories. 
 
-If the research project and the local situation allows, it might be good practice 
 17 
to document the whole materia medica or medicinal flora of a community or a 
population, not just parts thereof.  
 
-Consider the influence of globalization and the impact of popular media and 
scientific communications on local plant use and knowledge. 
 
-Specify means for dissemination of research results, outreach to participants, 
and access and benefit sharing arrangements (ABS). This may include 
outreach publications, local databases and knowledge exchange. 
 
-Include links to high-resolution scans (or digital photos) of the herbarium 
vouchers in either the main manuscript or as supplementary data.  
 
-To safeguard the intellectual property of study participants we suggest that 
every manuscript should include a statement similar to the following: "All work 
conducted was carried out under the stipulations of the Nagoya Protocol on 
Access to Genetic Resources and the Fair and Equitable Sharing of Benefits 
Arising from their Utilization to the Convention on Biological Diversity. The 
right to use and authorship of any traditional knowledge of all participants is 
maintained, and any use of this information, other than for scientific 
publication, does require additional prior consent of the traditional owners, as 
well as a consensus on access to benefits resulting from subsequent use." 
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